DESolve Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT02013349

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02013349
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Italy, Jordan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02013349. Allocation not applicable; no masking; primary purpose treatment. Start 2014-04-22 (actual); primary completion 2015-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DESolve Post-Approval Study
Intervention (Device)
coronary intervention
Lead sponsor
Elixir Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct02013349
Content hash
38dddc980be35328be7bc971393bc1d7370235be48fb6155249f278c39febdb6